| AD | Alzheimer’s disease |
| ALS | Amyotrophic lateral sclerosis |
| ANS | Autonomic nervous system |
| Aβ | Amyloid-beta |
| BBB | Blood–brain barrier |
| CNS | Central nervous system |
| ENS | Enteric nervous system |
| MGBA | Microbiota–Gut–brain axis |
| HD | Huntington’s disease |
| HPA | Hypothalamic–pituitary–adrenal |
| i.v. | Intravenous |
| L-DOPA | Orally administered levodopa |
| MCAO | Middle cerebral artery occlusion |
| MDD | Major depressive disorder |
| MS | Multiple sclerosis |
| OAE | Onchocerciasis-associated epilepsy |
| PD | Parkinson disease |
| ROS | Reactive oxygen species |
| SCFAs | Short-chain fatty acids |
| SLE | Systemic lupus erythematosus |
| SURG | Surgical resections for epilepsy |
| TDC | Tyrosine decarboxylase |